ConductScience.org, home

Trial · NCT01808313

Adverse events26

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
seriousPneumoniaInfections and infestationsAmbrisentan1134
seriousAscitesGastrointestinal disordersAmbrisentan1134
seriousDiarrhoeaGastrointestinal disordersAmbrisentan1134
seriousHaemorrhagic anaemiaBlood and lymphatic system disordersAmbrisentan1134
seriousCerebral haemorrhageNervous system disordersAmbrisentan1134
seriousCystitis glandularisRenal and urinary disordersAmbrisentan1134

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01808313/events?page=2